Mucosal B cells: Phenotypic characteristics, transcriptional regulation, and homing properties

Immunological Reviews

Volumn 206, Issue , 2005, Pages 32-63

  Brandtzaeg, Per ^a,b   Johansen, Finn Eirik ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADENOID; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BINDING AFFINITY; CELL MIGRATION; EFFECTOR CELL; EPITHELIUM CELL; GERMINAL CENTER; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOGLOBULIN PRODUCTION; INTESTINE LYMPHATIC TISSUE; LAMINA PROPRIA; LARGE INTESTINE; LYMPHOCYTE CLONE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE HOMING; LYMPHOID TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUTH CAVITY; MUCOSA ASSOCIATED LYMPHOID TISSUE; MUCOSA CELL; MUCOSAL IMMUNITY; NONHUMAN; PALATINE TONSIL; PLASMA CELL; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE; TRANSCRIPTION REGULATION; UROGENITAL SYSTEM;

ANIMALS; B-LYMPHOCYTES; CELL MOVEMENT; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, MUCOSAL; IMMUNOPHENOTYPING; TRANSCRIPTION, GENETIC;

EID: 23344453236     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2005.00283.x     Document Type: Review

References (338)

1. Brandtzaeg P, Carlsen HS, Farstad IN. The human mucosal B-cell system. In: Mestecky J, Lamm M, Strober W, Bienenstock J, McGhee J, Mayer L, eds. Mucosal Immunology, 3rd edn. Elsevier, London: Academic Press, 2005:617-654.
2. Brandtzaeg P, Farstad IN, Johansen F-E, Morton HC, Norderhaug IN, Yamanaka T. The B-cell system of human mucosae and exocrine glands. Immunol Rev 1999;171:45-87.
3. Kallies A, et al. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J Exp Med 2004;200:967-977.
4. Bartholdy B, Matthias P. Transcriptional control of B cell development and function. Gene 2004;18:1-23.
5. Mestecky J, McGhee JR. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 1987;40:153-245.
6. Brandtzaeg P, Prydz H. Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature 1984;311:71-73.
7. Johansen F-E, Braathen R, Brandtzaeg P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J Immunol 2001;167:5185-5192.
8. Brandtzaeg P. Mucosal and glandular distribution of immunoglobulin components. Differential localization of free and bound SC in secretory epithelial cells. J Immunol 1974;112:1553-1559.
9. Brandtzaeg P. Role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man. Scand J Immunol 1985;22:111-146.
10. Norderhaug IN, Johansen F-E, Schjerven H, Brandtzaeg P. Regulation of the formation and external transport of secretory immunoglobulins. Crit Rev Immunol 1999;19:481-508.
11. Brandtzaeg P. Presence of J chain in human immunocytes containing various immunoglobulin classes. Nature 1974;252:418-420.
12. Brandtzaeg P, Gjeruldsen ST, Korsrud F, Baklien K, Berdal P, Ek J. The human secretory immune system shows striking heterogeneity with regard to involvement of J chain positive IgD immunocytes. J Immunol 1979;122:503-510.
13. Johansen F-E, Braathen R, Brandtzaeg P. Role of J chain in secretory immunoglobulin formation. Scand J Immunol 2000;52:240-248.
14. Mazanec MB, Nedrud JG, Kaetzel CS, Lamm ME. A three-tiered view of the role of IgA in mucosal defense. Immunol Today 1993;14:430-435.
15. Brandtzaeg P. Role of secretory antibodies in the defence against infections. Int J Med Microbiol 2003;293:3-15.
16. Conley ME, Delacroix DL. Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense? Ann Intern Med 1987;106:892-899.
17. Persson CG, et al. Contribution of plasma-derived molecules to mucosal immune defence, disease and repair in the airways. Scand J Immunol 1998;47:302-313.
18. Yoshida M, et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 2004;20:769-783.
19. Brandtzaeg P, Tolo K. Mucosal penetrability enhanced by serum-derived antibodies. Nature 1977;266:262-263.
20. Johansen F-E, Brandtzaeg P. Transcriptional regulation of the mucosal IgA system. Trends Immunol 2004;25:150-157.
21. Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol 2004;25:570-577.
22. Neutra MR, Mantis NJ, Kraehenbuhl JP. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2001;2:1004-1009.
23. Craig SW, Cebra JJ. Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J Exp Med 1971;134:188-200.
24. McWilliams M, Phillips-Quagliata JM, Lamm ME. Mesenteric lymph node B lymphoblasts which home to the small intestine are precommitted to IgA synthesis. J Exp Med 1977;145:866-875.
25. McDermott MR, Bienenstock J. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol 1979;122:1892-1898.
26. Guy-Grand D, Griscelli C, Vassalli P. The gut-associated lymphoid system: nature and properties of the large dividing cells. Eur J Immunol 1974;4:435-443.
27. Roux ME, McWilliams M, Phillips-Quagliata JM, Lamm ME. Differentiation pathway of Peyer's patch precursors of IgA plasma cells in the secretory immune system. Cell Immunol 1981;61:141-153.
28. Parrott DM. The gut as a lymphoid organ. Clin Gastroenterol 1976;5:211-228.
29. Lamm ME. Cellular aspects of immunoglobulin A. Adv Immunol 1976;22:223-290.
30. Cornes JS. Number, size and distribution of Peyer's patches in the human small intestine. Gut 1965;6:225-233.
31. Trepel F. Number and distribution of lymphocytes in man. A critical analysis. Klin Wochenschr 1974;52:511-515.
32. Moghaddami M, Cummins A, Mayrhofer G. Lymphocyte-filled villi: comparison with other lymphoid aggregations in the mucosa of the human small intestine. Gastroenterology 1998;115:1414-1425.
33. O'Leary AD, Sweeney EC. Lymphoglandular complexes of the colon: structure and distribution. Histopathology 1986;10:267-283.
34. Hamada H, et al. Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J Immunol 2002;168:57-64.
35. Yamamoto M, et al. Role of gut-associated lymphoreticular tissues in antigen-specific intestinal IgA immunity. J Immunol 2004;173:762-769.
36. Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H, Hiai H, Honjo T. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 2002;298:1424-1427.
37. Suzuki K, et al. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci USA 2004;101:1981-1986.
38. Brandtzaeg P. Immune functions and immunopathology of palatine and nasopharyngeal tonsils. In: Bernstein JM, Ogra PL, eds. Immunology of the Ear. New York: Raven Press, 1987:63-106.
39. Brandtzaeg P, Halstensen TS. Immunology and immunopathology of tonsils. Adv Otorhinolaryngol 1992;47:64-75.
40. Perry M, Whyte A. Immunology of the tonsils. Immunol Today 1998;19:414-421.
41. Tschernig T, Pabst R. Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiology 2000;68:1-8.
42. Debertin AS, Tschernig T, Tonjes H, Kleemann WJ, Troger HD, Pabst R. Nasal-associated lymphoid tissue (NALT): frequency and localization in young children. Clin Exp Immunol 2003;134:503-507.
43. Kuper CF, et al. The role of nasopharyngeal lymphoid tissue. Immunol Today 1992;13:219-224.
44. Yanagita M, et al. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production. J Immunol 1999;162:3559-3565.
45. Shimoda M, et al. Isotype-specific selection of high affinity memory B cells in nasal-associated lymphoid tissue. J Exp Med 2001;194:1597-1607.
46. Brandtzaeg P, et al. Regional specialization in the mucosal immune system: what happens in the microcompartments? Immunol Today 1999;20:141-151.
47. von Gaudecker B, Muller-Hermelink HK. The development of the human tonsilla palatina. Cell Tissue Res 1982;224:579-600.
48. + cells. Immunity 2002;17:31-40.
49. Moyron-Quiroz JE, et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004;10:927-934.
50. Yoshida H, et al. Different cytokines induce surface lymphotoxin- αβ on IL-7 receptor-α cells that differentially engender lymph nodes and Peyer's patches. Immunity 2002;17:823-833.
51. Chaplin DD, Fu Y. Cytokine regulation of secondary lymphoid organ development. Curr Opin Immunol 1998;10:289-297.
52. - cells induce Peyer's patch development: role of α4β1 integrin activation by CXCR5. Immunity 2002;17:363-373.
53. Kiyono H, Fukuyama S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 2004;4:699-710.
54. Lorenz RG, Chaplin DD, McDonald KG, McDonough JS, Newberry RD. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin- sufficient B lymphocytes, lymphotoxin β receptor, and TNF receptor I function. J Immunol 2003;170:5475-5482.
55. Harmsen A, et al. Cutting edge: organogenesis of nasal-associated lymphoid tissue (NALT) occurs independently of lymphotoxin-α (LTα) and retinoic acid receptor-related orphan receptor-γ, but the organization of NALT is LTα dependent. J Immunol 2002;168:986-990.
56. + T cells activated in cutaneous or mucosal lymphoid tissues. J Exp Med 2002;195:135-141.
57. Rescigno M, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001;2:361-367.
58. 3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005;307:254-258.
59. Jahnsen FL, Gran E, Haye R, Brandtzaeg P. Human nasal mucosa contains antigen-presenting cells of strikingly different functional phenotypes. Am J Respir Cell Mol Biol 2004;30:31-37.
60. Rugtveit J, Bakka A, Brandtzaeg P. Differential distribution of B7.1 (CD80) and B7.2 (CD86) co-stimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD). Clin Exp Immunol 1997;110:104-113.
61. Yamanaka T, Straumfors A, Morton HC, Fausa O, Brandtzaeg P, Farstad IN. M cell pockets of human Peyer's patches are specialized extensions of germinal centers. Eur J Immunol 2001;31:107-117.
62. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004;303:1662-1665.
63. Macpherson AJ, Geuking MB, McCoy KD. Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology 2005;115:153-162.
64. Kroese FG, Butcher EC, Stall AM, Lalor PA, Adams S, Herzenberg LA. Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int Immunol 1989;1:75-84.
65. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000;288:2222-2226.
66. Fagarasan S, Honjo T. Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol 2003;3:63-72.
67. Fagarasan S, Kinoshita K, Muramatsu M, Ikuta K, Honjo T. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 2001;413:639-643.
68. Brandtzaeg P, Baekkevold ES, Morton HC. From B to A the mucosal way. Nat Immunol 2001;2:1093-1094.
69. H gene analysis suggests that peritoneal B cells do not contribute to the gut immune system in man. Eur J Immunol 2002;32:2427-2436.
70. Bouvet JP, Fischetti VA. Diversity of antibody-mediated immunity at the mucosal barrier. Infect Immun 1999;67:2687-2691.
71. Rhee KJ, Sethupathi P, Driks A, Lanning DK, Knight KL. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J Immunol 2004;172:1118-1124.
72. Casola S, et al. B cell receptor signal strength determines B cell fate. Nat Immunol 2004;5:317-327.
73. Brandtzaeg P, et al. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989;97:1562-1584.
74. Farstad IN, Halstensen TS, Lazarovits AI, Norstein J, Fausa O, Brandtzaeg P. Human intestinal B-cell blasts and plasma cells express the mucosal homing receptor integrin α4β7. Scand J Immunol 1995;42:662-672.
75. Farstad IN, Carlsen H, Morton HC, Brandtzaeg P. Immunoglobulin A cell distribution in the human small intestine: phenotypic and functional characteristics. Immunology 2000;101:354-363.
76. Roux ME, McWilliams M, Phillips-Quagliata JM, Weisz-Carrington P, Lamm ME. Origin of IgA-secreting plasma cells in the mammary gland. J Exp Med 1977;146:1311-1322.
77. Brandtzaeg P. The secretory immune system of lactating human mammary glands compared with other exocrine organs. Ann N Y Acad Sci 1983;409:353-381.
78. Crago SS, et al. Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J Immunol 1984;132:16-18.
79. Jonard PP, Rambaud JC, Dive C, Vaerman JP, Galian A, Delacroix DL. Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A. J Clin Invest 1984;74:52S-535.
80. Kett K, Brandtzaeg P, Radl J, Haaijman JJ. Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol 1986;136:3631-3635.
81. Burnett D, Crocker J, Stockley RA. Cells containing IgA subclasses in bronchi of subjects with and without chronic obstructive lung disease. Clin Pathol 1987;40:1217-1220.
82. Kilian M, Reinholdt J, Lomholt H, Poulsen K, Frandsen EV. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. APMIS 1996;104:321-338.
83. Müller F, Frøland SS, Hvatum M, Radl J, Brandtzaeg P. Both IgA subclasses are reduced in parotid saliva from patients with AIDS. Clin Exp Immunol 1991;83:203-209.
84. Feltelius N, Hvatum M, Brandtzaeg P, Knutson L, Hällgren R. Increased jejunal secretory IgA and IgM in ankylosing spondylitis: normalization after treatment with sulfasalazine. J Rheumatol 1994;21:2076-2081.
85. Brandtzaeg P. Human secretory component. VI. Immunoglobulin-binding properties. Immunochemistry 1977;14:179-188.
86. Mestecky J, Russell MW. IgA subclasses. Monogr Allergy 1986;19:277-301.
87. Tarkowski A, Lue C, Moldoveanu Z, Kiyono H, McGhee JR, Mestecky J. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses. J Immunol 1990;144:3770-3778.
88. Kett K, Baklien K, Bakken A, Krai JG, Fausa O, Brandtzaeg P. Intestinal B-cell isotype response in relation to local bacterial load: evidence for immunoglobulin A subclass adaptation. Gastroenterology 1995;109:819-825.
89. Brandtzaeg P, Karlsson G, Hansson G, Petruson B, Björkander J, Hanson LÅ. The clinical condition of IgA-deficient patients is related to the proportion of IgD- and IgM-producing cells in their nasal mucosa. Clin Exp Immunol 1987;67:626-636.
90. Valnes K, Brandtzaeg P, Elgjo K, Stave R. Quantitative distribution of immunoglobulin-producing cells in gastric mucosa: relation to chronic gastritis and glandular atrophy. Gut 1986;27:505-514.
91. Brandtzaeg P, Haraldsen G, Rugtveit J. Immunopathology of human inflammatory bowel disease. Springer Semin Immunopathol 1997;18:555-589.
92. Brandtzaeg P, Carlsen HS, Halstensen TS. The B-cell system in inflammatory bowel disease (IBD). In: Blumberg RS, Neurath MF, eds. Immune Mechanisms in Inflammatory Bowel Disease. Georgetown, New York: Landes Bioscience and Springer Sceience + Business Media, 2005 (in press).
93. Kett K, Brandtzaeg P. Local IgA subclass alterations in ulcerative colitis and Crohn's disease of the colon. Gut 1987;28:1013-1021.
94. Brandtzaeg P, Korsrud FR. Significance of different J chain profiles in human tissues: generation of IgA and IgM with binding site for secretory component is related to the J chain expressing capacity of the total local immunocyte population, including IgG and IgD producing cells, and depends on the clinical state of the tissue. Clin Exp Immunol 1984;58:709-718.
95. Kett K, Brandtzaeg P, Fausa O. J-chain expression is more prominent in immunoglobulin A2 than in immunoglobulin A1 colonic immunocytes and is decreased in both subclasses associated with inflammatory bowel disease. Gastroenterology 1988;94:1419-1425.
96. Nilssen DE, et al. Isotype distribution of mucosal IgG-producing cells in patients with various IgG-subclass deficiencies. Clin Exp Immunol 1991;83:17-24.
97. Bjerke K, Brandtzaeg P. Terminally differentiated human intestinal B cells. IgA and IgG subclass-producing immunocytes in the distal ileum, including Peyer's patches, compared with lymph nodes and palatine tonsils. Scand J Immunol 1990;32:61-67.
98. Helgeland L, et al. The IgG subclass distribution in serum and rectal mucosa of monozygotic twins widi or without inflammatory bowel disease. Gut 1992;33:1358-1364.
99. Flanagan JG, Rabbitts TH. Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing γ, ε and α genes. Nature 1982;300:709-713.
100. Papadea C, Check IJ. Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic, and clinical aspects. Crit Rev Clin Lab Sci 1989;27:27-58.
101. Korsrud FR, Brandtzaeg P. Quantitative immunohistochemistry of immunoglobulin- and J-chain-producing cells in human parotid and submandibular glands. Immunology 1980;39:129-140.
102. Rognum TO, Brandtzaeg P. IgE-positive cells in human intestinal mucosa are mainly mast cells. Int Arch Allergy Appl Immunol 1989;89:256-260.
103. Brewer JW, Randall TD, Parkhouse RM, Corley RB. IgM hexamers? Immunol Today 1994;15:165-168.
104. Wiersma EJ, Collins C, Fazel S, Shulman MJ. Structural and functional analysis of J chain-deficient IgM. J Immunol 1998;160:5979-5989.
105. 414 and the secretory tailpiece. J Immunol 1999;162:3448-3455.
106. Braathen R, Sørensen V, Brandtzaeg P, Sandlie I, Johansen F-E. The carboxyl-terminal domains of IgA and IgM direct isotype-specific polymerization and interaction with the polymeric immunoglobulin receptor. J Biol Chem 2002;277:42755-42762.
107. Brandtzaeg P. Two types of IgA immunocytes in man. Nat New Biol 1973;243:142-143.
108. Brandtzaeg P. Immunohistochemical characterization of intracellular J-chain and binding site for secretory component (SC) in human immunoglobulin (Ig)-producing cells. Mol Immunol 1983;20:941-966.
109. Eskeland T, Brandtzaeg P. Does J chain mediate the combination of 19S IgM and dimeric IgA with the secretory component rather than being necessary for their polymerization? Immunochemistry 1974;11:161-163.
110. Bjerke K, Brandtzaeg P. Terminally differentiated human intestinal B cells. J chain expression of IgA and IgG subclass-producing immunocytes in the distal ileum compared with mesenteric and peripheral lymph nodes. Clin Exp Immunol 1990;82:411-415.
111. Nagura H, Brandtzaeg P, Nakane PK, Brown WR. Ultrastructural localization of J chain in human intestinal mucosa. J Immunol 1979;23:1044-1050.
112. Moro I, Iwase T, Komiyama K, Moldoveanu Z, Mestecky J. Immunoglobulin A (IgA) polymerization sites in human immunocytes: immunoelectron microscopic study. Cell Struct Funct 1990;15:85-91.
113. Bjerke K, Brandtzaeg P, Rognum TO. Distribution of immunoglobulin producing cells is different in normal human appendix and colon mucosa. Gut 1986;27:667-674.
114. Nilssen DE, Brandtzaeg P, Frøland SS, Fausa O. Subclass composition and J-chain expression of the 'compensatory' IgG-cell population in selective IgA deficiency. Clin Exp Immunol 1992;87:237-245.
115. Mosmann TR, Gravel Y, Williamson AR, Baumal R. Modification and fate of J chain in myeloma cells in the presence and absence of polymeric immunoglobulin secretion. Eur J Immunol 1978;8:94-101.
116. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996;272:54-60.
117. Korsrud FR, Brandtzaeg P. Immunohistochemical evaluation of J-chain expression by intra- and extra-follicular immunoglobulin-producing human tonsillar cells. Scand J Immunol 1981;13:271-280.
118. Bjerke K, Brandtzaeg P. Immunoglobulin- and J-chain-producing cells associated with the lymphoid follicles of human appendix, colon and ileum, including the Peyer's patches. Clin Exp Immunol 1986;64:432-441.
119. Tigges MA, Casey LS, Koshland ME. Mechanism of interleukin-2 signaling: mediation of different outcomes by a single receptor and transduction pathway. Science 1989;243:781-786.
120. S and J chain mRNA in a clonal B cell line, but differ in their cell-cycle dependency for optimal signaling. Cell Immunol 1991;136:472-485.
121. Randall TD, Parkhouse RME, Corley RB. J chain synthesis and secretion of hexameric IgM is differentially regulated by lipolysaccharide and interleukin 5. Proc Natl Acad Sci USA 1992;89:962-966.
122. Shin MK, Koshland ME. Ets-related protein PU.1 regulates expression of the immunoglobulin J-chain gene through a novel Ets-binding element. Genes Dev 1993;7:2006-2015.
123. Kang CJ, Sheridan C, Koshland ME. A stage-specific enhancer of immunoglobulin J chain gene is induced by interleukin-2 in a presecretor B cell stage. Immunity 1998;8:285-295.
124. Rao S, Karray S, Gackstetter ER, Koshland ME. Myocyte enhancer factor-related B-MEF2 is developmentally expressed in B cells and regulates the immunoglobulin J chain promoter. J Biol Chem 1998;273:26123-26129.
125. Turner CA, Mack DH, Davis MM. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin- secreting cells. Cell 1994;77:297-306.
126. Wallin JJ, Rinkenberger JL, Rao S, Gackstetter ER, Koshland ME, Zwollo P. B cell-specific activator protein prevents two activator factors from binding to the immuno globulin J chain promoter until the antigen-driven stages of B cell development. J Biol Chem 1999;274:15959-15965.
127. Lansford RD, McFadden HJ, Siu ST, Cox JS, Cann GM, Koshland ME. A promoter element that exerts positive and negative control of the interleukin 2-responsive J-chain gene. Proc Natl Acad Sci USA 1992;89:5966-5970.
128. McCune JM, Fu SM, Kunkel HG. J chain biosynthesis in pre-B cells and other possible precursor B cells. J Exp Med 1981;154:138-145.
129. Hajdu I, Moldoveanu Z, Cooper MD, Mestecky J. Ultrastructural studies of human lymphoid cells, μ and J chain expression as a function of B cell differentiation. J Exp Med 1983;158:1993-2006.
130. Kubagawa H, Burrows PD, Grossi CE, Mestecky J, Cooper MD. Precursor B cells transformed by Epstein-Barr virus undergo sterile plasma-cell differentiation: J-chain expression without immunoglobulin. Proc Natl Acad Sci USA 1988;85:875-879.
131. Max EE, Korsmeyer SJ. Human J chain gene. Structure and expression in B lymphoid cells. J Exp Med 1985;161:832-849.
132. Bertrand FE III, Billips LG, Gartland GL, Kubagawa H, Schroeder HW Jr. The J chain gene is transcribed during B and T lymphopoiesis in humans. J Immunol 1996;156:4240-4244.
133. Park HS, Francis KP, Yu J, Cleary PP. Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus. J Immunol 2003;171:2532-2537.
134. Bjerke K, Brandtzaeg P. Lack of relation between expression of HLA-DR and secretory component (SC) in follicle-associated epithelium of human Peyer's patches. Clin Exp Immunol 1988;71:502-507.
135. + dendritic cells. J Immunol 2003;171:2797-2803.
136. Erratum in: J Immunol 2004 June 1;172(11):7220.
137. Rumbo M, Sierro F, Debard N, Kraehenbuhl JP, Finke D. Lymphotoxin β receptor signaling induces the chemokine CCL20 in intestinal epithelium. Gastroenterology 2004;127:213-223.
138. Bjerke K, Halstensen TS, Jahnsen F, Pulford K, Brandtzaeg P. Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes. Gut 1993;34:1357-1363.
139. Farstad IN, Halstensen TS, Fausa O, Brandtzaeg P. Heterogeneity of M-cell-associated B and T cells in human Peyer's patches. Immunology 1994;83:457-464.
140. Kernéis S, Bogdanova A, Kraehenbuhl J-P, Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 1997;277:949-952.
141. Yamanaka T, Helgeland L, Farstad IN, Midtvedt T, Fukushima H, Brandtzaeg P. Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J Immunol 2003;170:816-822.
142. Liu Y-J, Barthélémy C, de Bouteiller O, Arpin C, Durand I, Banchereau J. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity 1995;2:239-248.
143. Roy MJ, Varvayanis M. Development of dome epithelium in gut-associated lymphoid tissues: association of IgA with M cells. Cell Tissue Res 1987;248:645-651.
144. Mantis NJ, Cheung MC, Chintalacharuvu KR, Rey J, Corthesy B, Neutra MR. Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor. J Immunol 2002;169:1844-1851.
145. Rey J, Garin N, Spertini F, Corthesy B. Targeting of secretory IgA to Peyer's patch dendritic and T cells after transport by intestinal M cells. J Immunol 2004;172:3026-3033.
146. Brandtzaeg P, Fjellanger I, Gjeruldsen ST. Adsorption of immunoglobulin A onto oral bacteria in vivo. J Bacteriol 1968;96:242-249.
147. van der Waaij LA, Limburg PC, Mesander G, van der Waaij D. In vivo IgA coating of anaerobic bacteria in human faeces. Gut 1996;38:348-354.
148. Shroff KE, Meslin K, Cebra JJ. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect Immun 1995;63:3904-3913.
149. Brandtzaeg P. The secretory immunoglobulin system: regulation and biological significance. Focusing on mammary glands. In: Davis MK, Isaacs CE, Hanson LÅ, Wright AL, eds. Integrating Population Outcomes, Biological Mechanisms and Research Methods in the Study of Human Milk and Lactation. New York: Kluwer Academic/ Plenum Publishers, Adv Exp Med Biol 2002;503:1-16.
150. Kapasi ZF, et al. Follicular dendritic cell (FDC) precursors in primary lymphoid tissues. J Immunol 1998;160:1078-1084.
151. Gommerman JL, Mackay F, Donskoy E, Meier W, Martin P, Browning JL. Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway. J Clin Invest 2002;110:1359-1369.
152. Fu YX, Huang G, Wang Y, Chaplin DD. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin α-dependent fashion. J Exp Med 1998;187:1009-1018.
153. Tumanov A, et al. Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity 2002;17:239-250.
154. Tumanov AV, Kuprash DV, Mach JA, Nedospasov SA, Chervonsky AV. Lymphotoxin and TNF produced by B cells are dispensable for maintenance of the follicle-associated epithelium but are required for development of lymphoid follicles in the Peyer's patches. J Immunol 2004;173:86-91.
155. MacLennan ICM. Germinal centers. Annu Rev Immunol 1994;12:117-139.
156. Liu Y-J, Arpin C. Germinal center development. Immunol Rev 1997;156:111-126.
157. Manser T. Textbook germinal centers? J Immunol 2004;172:3369-3375.
158. MacLennan ICM, et al. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol Rev 1997;156:53-66.
159. Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 1998;281:96-99.
160. Lebecque S, de Bouteiller O, Arpin C, Banchereau J, Liu YJ. Germinal center founder cells display propensity for apoptosis before onset of somatic mutation. J Exp Med 1997;185:563-571.
161. Lindhout E, Koopman G, Pals ST, de Groot C. Triple check for antigen specificity of B cells during germinal centre reactions. Immunol Today 1997;18:573-577.
162. Ehrenstein MR, O'Keefe TL, Davies SL, Neuberger MS. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci USA 1998;95:10089-10093.
163. Tarlinton D. Germinal centers: form and function. Curr Opin Immunol 1998;10:245-251.
164. Macpherson AJ, et al. IgA production without μ or δ chain expression in developing B cells. Nat Immunol 2001;2:625-631.
165. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999;286:2098-2102.
166. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001;2:123-128.
167. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 1998;187:655-660.
168. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998;391:799-803.
169. Förster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996;87:1037-1047.
170. Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 2000;12:471-481.
171. Ansel KM, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000;406:309-314.
172. Bleul CC, Schultze JL, Springer TA. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J Exp Med 1998;187:753-762.
173. Carlsen HS, Baekkevold ES, Johansen F-E, Haraldsen G, Brandtzaeg P. B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut 2002;51:364-371.
174. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 2000;192:1553-1562.
175. Breitfeld D, et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 2000;192:1545-1552.
176. + T cells: follicular horning takes center stage in T-helper-cell responses. Trends Immunol 2002;23:250-254.
177. Chtanova T, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol 2004;173:68-78.
178. + T cells. J Exp Med 2001;193:1373-1381.
179. Grouard G, Durand I, Filgueira L, Banchereau J, Liu Y-J. Dendritic cells capable of stimulating T cells in germinal centres. Nature 1996;384:364-367.
180. Carlsen HS, Baekkevold ES, Morton HC, Haraldsen G, Brandtzaeg P. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood 2004;104:3021-3027.
181. Pulendran B, van Driel R, Nossal GJV. Immunological tolerance in germinal centres. Immunol Today 1997;18:27-32.
182. Randall TD, Heath AW, Santos-Argumedo L, Howard MC, Weissman IL, Lund FE.
183. Arpin C, Banchereau J, Liu YJ. Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing. J Exp Med 1997;186:931-940.
184. Agematsu K, Hokibara S, Nagumo H, Komiyama A. CD27: a memory B-cell marker. Immunol Today 2000;21:204-206.
185. Jung J, Choe J, Li L, Choi YS. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. Eur J Immunol, 2000;30:2437-2443.
186. Toellner KM, et al. Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers. J Exp Med 2002;195:383-389.
187. Stoel M, et al. Restricted IgA repertoire in both B-1 and B-2 cell-derived gut plasmablasts. J Immunol 2005;174:1046-1054.
188. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002;298:2199-2202.
189. Reif K, et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 2002;416:94-99.
190. Bowman EP, et al. The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med 2002;195:269-275.
191. + Payer's patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells. J Immunol 2003;171:3684-3690.
192. Litinskiy MB, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002;3:822-829.
193. Castigli E, et al. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA 2004;101:3903-3908.
194. Kinoshita K, Honjo T. Linking class-switch recombination with somatic hypermutation. Nat Rev Mol Cell Biol 2001;2:493-503.
195. Chaudhuri J, Alt FW. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol 2004;4:541-552.
196. Lin YC, Stavnezer J. Regulation of transcription of the germ-line Igα constant region gene by an ATF element and by novel transforming growth factor-β1-responsive elements. J Immunol 1992;149:2914-2925.
197. Islam KB, Nilsson L, Sideras P, Hammarstrom L, Smith CI. TGF-β 1 induces germ-line transcripts of both IgA subclasses in human B lymphocytes. Int Immunol 1991;3:1099-1106.
198. Park SR, Lee JH, Kim PH. Smad3 and Smad4 mediate transforming growth factor-β1-induced IgA expression in murine B lymphocytes. Eur J Immunol 2001;31:1706-1715.
199. Cazac BB, Roes J. TGF-β receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 2000;13:443-451.
200. Zan H, Cerutti A, Dramitinos P, Schaffer A, Casali P. CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF β: evidence for TGF β but not IL 10 dependent direct Aμ→Sα and sequential Sμ→Sγ, Sγ→Sα DNA recombination. J Immunol 1998;161:5217-5225.
201. Shi MJ, Stavnezer J. CBFα3 (AML2) is induced by TGF-β1 to bind and activate the mouse germline Ig α promoter. J Immunol 1998;161:6751-6760.
202. Shi MJ, Park SR, Kim PH, Stavnezer J. Roles of Ets proteins, NF-κB and nocodazole in regulating induction of transcription of mouse germline Ig α RNA by transforming growth factor-β 1. Int Immunol 2001;13:733-746.
203. Hanai J, et al. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Cα promoter. J Biol Chem 1999;274:31577-31582.
204. Pardali E, et al. Smad and AML proteins synergistically confer transforming growth factor β1 responsiveness to human germline IgA genes. J Biol Chem 2000;275:3552-3560.
205. Zhang Y, Derynck R. Transcriptional regulation of the transforming growth factor-β-inducible mouse germ line Ig α constant region gene by functional cooperation of Smad, CREB, and AML family members. J Biol Chem 2000;275:16979-16985.
206. Qiu G, Stavnezer J. Overexpression of BSAP/Pax-5 inhibits switching to IgA and enhances switching to IgE in the 1.29 mu B cell line. J Immunol 1998;161:2906-2918.
207. Conley ME, Bartelt MS. In vitro regulation of IgA subclass synthesis. II. The source of IgA2 plasma cells. J Immunol 1984;133:2312-2316.
208. H gene, Cμ-Cδ switch, and λ light chain expression. J Exp Med 1998;187:1169-1178.
209. Johansen F-E, Baekkevold ES, Carlsen HS, Farstad IN, Soler D, Brandtzaeg P. Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils. Blood 2005;106:593-600.
210. Janson H, Hedén L-O, Grubb A, Ruan M, Forsgren A. Protein D, an immunoglobulin D-binding protein of Haemophilus influenzae: cloning, nucleotide sequence, and expression in Escherichia coli. Infect Immun 1991;59:119-125.
211. Liu Y-J, et al. Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development. Semin Immunol 1996;8:169-177.
212. Carsetti R, Kohler G, Lamers MC. A role for immunoglobulin D: interference with tolerance induction. Eur J Immunol 1993;23:168-178.
213. Terashima M, et al. The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J 1994;13:3782-3792.
214. Parkhouse RME, Cooper MD. A model for the differentiation of B lymphocytes with implications for the biological role of IgD. Immunol Rev 1977;37:105-126.
215. Zheng N-Y, et al. Human immunoglobulin selection associated with class switch and possible tolerogenic origins for Co class-switched B cells. J Clin Invest 2004;113:1188-1201.
216. Preud'homme JL, Petit I, Barra A, Morel F, Lecron JC, Lelievre E. Structural and functional properties of membrane and secreted IgD. Mol Immunol 2000;37:871-887.
217. Brandtzaeg P, Jahnsen FL, Farstad IN, Haraldsen G. Mucosal immunology of the upper airways: an overview. Ann N Y Acad Sci 1997;830:1-18.
218. Drenth JP, Goertz J, Daha MR, van der Meer JW. Immunoglobulin D enhances the release of tumor necrosis factor-α, and interleukin-1β as well as interleukin-1 receptor antagonist from human mononuclear cells. Immunology 1996;88:3S5-362.
219. Schrader CE, George A, Kerlin RL, Cebra JJ. Dendritic cells support production of IgA and other non IgM isotypes in clonal microculture. Int Immunol 1990;2:563-570.
220. Fayette J, et al. Human dendritic cells skew isotype switching of CD40 activated naive B cells towards IgA1 and IgA2. J Exp Med 1997;185:1909-1918.
221. Nilsen EM, Lundin KEA, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten-specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon γ. Gut 1995;37:766-776.
222. Hauer AC, Bajaj-Elliott M, Williams CB, Walker-Smith JA, MacDonald TT. An analysis of interferon γ, IL-4, IL-5 and IL-10 production by ELISPOT and quantitative reverse transcriptase-PCR in human Peyer's patches. Cytokine 1998;10:627-634.
223. MacDonald TT, Monteleone G. IL-12 and Th1 immune responses in human Peyer's patches. Trends Immunol 2001;22:244-247.
224. Fujihashi K, et al. Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. J Clin Invest 1991;88:248-252.
225. Briére F, et al. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest 1994;94:97-104.
226. Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992;175:671-682.
227. Austin AS, Haas KM, Naugler SM, Bajer AA, Garcia-Tapia D, Estes DM. Identification and characterization of a novel regulatory factor: IgA-inducing protein. J Immunol 2003;171:1336-1342.
228. Kimata H, Fujimoto M. Induction of IgA1 and IgA2 production in immature human fetal B cells and pre B cells by vasoactive intestinal peptide. Blood 1995;85:2098-2104.
229. Boirivant M, Fais S, Annibale B, Agostini D, Delle Fave G, Pallone F. Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytes. Gastroenterology 1994;106:576-582.
230. Pascual DW, Xu Amano JC, Kiyono H, McGhee JR, Bost KL. Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production. J Immunol 1991;146:2130-2136.
231. Bos NA, et al. Monoclonal immunoglobulin A derived from peritoneal B cells is encoded by both germ line and somatically mutated VH genes and is reactive with commensal bacteria. Infect Immun 1996;64:616-623.
232. Fagarasan S, Honjo T. T-Independent immune response: new aspects of B cell biology. Science 2000;290:89-92.
233. Dunn-Walters DK, Boursier L, Spencer J. Hypermutation, diversity and dissemination of human intestinal lamina propria plasma cells. Eur J Immunol 1997;27:2959-2964.
234. H region genes. Eur J Immunol 1998;28:2971-2977.
235. H genes used by human intestinal plasma cells from childhood. Immunology 1999;97:558-564.
236. Dunn-Walters DK, et al. Characteristics of human IgA and IgM genes used by plasma cells in the salivary gland resemble those used in duodenum but not those used in the spleen. J Immunol 2000;164:1595-1601.
237. Holtmeier W, Hennemann A, Caspary WF. IgA and IgM V(H) repertoires in human colon: evidence for clonally expanded B cells that are widely disseminated. Gastroenterology 2000;119:1253-1266.
238. H genes indicates that ileal lamina propria plasma cells are derived from Peyer's patches. Eur J Immunol 1997;27:463-467.
239. Cameron L, Gounni AS, Frenkiel S, Lavigne F, Vercelli D, Hamid Q. SεSμ and SεSγ switch circles in human nasal mucosa following ex vivo allergen challenge: evidence for direct as well as sequential class switch recombination. J Immunol 2003;171:3816-3822.
240. Shikina T, et al. IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut. J Immunol 2004;172:6259-6264.
241. Hiroi T, Yanagita M, Ohta N, Sakaue G, Kiyono H. IL-15 and IL-15 receptor selectively regulate differentiation of common mucosal immune system-independent B-1 cells for IgA responses. J Immunol 2000;165:4329-4337.
242. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-66.
243. Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002;16:1-4.
244. Brandtzaeg P, Farstad IN, Haraldsen G. Regional specialization in the mucosal immune system: primed cells do not always home along the same track. Immunol Today 1999;20:267-277.
245. Streeter PR, Berg EL, Rouse BT, Bargatze RF, Butcher EC. A tissue specific endothelial cell molecule involved in lymphocyte homing. Nature 1988;331:41-46.
246. Berg EL, McEvoy LM, Berlin C, Bargatze RF, Butcher EC. L selectin mediated lymphocyte rolling on MAdCAM 1. Nature 1993;366:695-698.
247. Berlin C, et al. α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995;80:413-422.
248. Pachynski RK, Wu SW, Gunn MD, Erle DJ. Secondary lymphoid tissue chemokine (SLC) stimulates integrin α4β7 mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule 1 (MAdCAM 1) under flow. J Immunol 1998;161:952-956.
249. Farstad IN, Halstensen TS, Lien B, Kilshaw PJ, Lazarovits AI, Brandtzaeg P. Distribution of β7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue. Immunology 1996;89:227-237.
250. Farstad IN, Halstensen TS, Kvale D, Fausa O, Brandtzaeg P. Topographic distribution of homing receptors on B and T cells in human gut-associated lymphoid tissue. Relation of L-selectin and integrin α4β7 to naive and memory phenotypes. Am J Pathol 1997;150:187-199.
251. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392:565-568.
252. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemo-taxis of naive T lymphocytes. Proc Natl Acad Sci USA 1998;95:258-263.
253. Campbell JJ, et al. 6 C kine (SLC), a lymphocyte adhesion triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7. J Cell Biol 1998;141:1053-1059.
254. Willimann K, et al. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur J Immunol 1998;28:2025-2034.
255. Baekkevold ES, et al. The CCR7 ligand ELC (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J Exp Med 2001;193:1105-1111.
256. Carlsen HS, Haraldsen G, Brandtzaeg P, Baekkevold ES. Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules. Blood 2005;106:444-446.
257. Okada T, et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 2002;196:65-75.
258. Warnock RA, Campbell JJ, Dorf ME, Matsuzawa A, McEvoy LM, Butcher EC. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J Exp Med 2000;191:77-88.
259. Farstad IN, Norstein J, Brandtzaeg P. Phenotypes of B and T cells in human intestinal and mesenteric lymph. Gastroenterology 1997;112:163-173.
260. Fujisaka M, Ohtani O, Watanabe Y. Distribution of lymphatics in human palatine tonsils: a study by enzyme histochemistry and scanning electron microscopy of lymphatic corrosion casts. Arch Histol Cytol 1996;59:273-280.
261. Irjala H, et al. The same endothelial receptor controls lymphocyte traffic both in vascular and lymphatic vessels. Eur J Immunol 2003;33:815-824.
262. Bradley LM, Watson SR. Lymphocyte migration into tissue: the paradigm derived from CD4 subsets. Curr Opin Immunol 1996;8:312-320.
263. Rott LS, Briskin MJ, Andrew DP, Berg EL, Butcher EC. A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule 1. Comparison with vascular cell adhesion molecule 1 and correlation with β7 integrins and memory differentiation. J Immunol 1996;156:3727-3736.
264. Quiding-Järbrink M, et al. Human circulating specific antibody forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers. Eur J Immunol 1995;25:322-327.
265. Quiding-Järbrink M, et al. Differential expression of tissue specific adhesion molecules on human circulating antibody forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J Clin Invest 1997;99:1281-1286.
266. Kantele JM, et al. Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology 1996;110:1061-1067.
267. Kantele A, et al. Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody secreting cells that all bear homing receptors directing them to the gut. J Immunol 1997;158:574-579.
268. Kunkel EJ, et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med 2000;192:761-768.
269. Papadakis KA, et al. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol 2000;165:5069-5076.
270. Pabst O, et al. Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. J Exp Med 2004;199:411-416.
271. Hieshima K, et al. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells. J Immunol 2004;173:3668-3675.
272. Williams IR. Chemokine receptors and leukocyte trafficking in the mucosal immune system. Immunol Res 2004;29:283-292.
273. Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of α4β7 integrin. Eur J Immunol 2002;32:1445-1454.
274. Mora JR, et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 2003;424:88-93.
275. Johansson-Lindbom B, Svensson M, Wurbel MA, Malissen B, Marquez G, Agace W. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med 2003;198:963-969.
276. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004;21:527-538.
277. Hieshima K, et al. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J Immunol 2003;170:1452-1461.
278. Kunkel EJ, et al. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest 2003;111:1001-1010.
279. Lazarus NH, Kunkel EJ, Johnston B, Wilson E, Youngman KR, Butcher EC. A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J Immunol 2003;170:3799-3805.
280. Pan J, et al. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol 2000;165:2943-2949.
281. Wang W, et al. Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem 2000;275:22313-22323.
282. Crabbé PA, Nash DR, Bazin H, Eyssen H, Heremans JF. Immunohistochemical observations on lymphoid tissues from conventional and germ-free mice. Lab Invest 1970;22:448-457.
283. Mayrhofer G, Fisher R. IgA-containing plasma cells in the lamina propria of the gut: failure of a thoracic duct fistula to deplete the numbers in rat small intestine. Eur J Immunol 1979;9:85-91.
284. Gerdts V, et al. Multiple intestinal 'loops' provide an in vivo model to analyse multiple mucosal immune responses. J Immunol Methods 2001;256:19-33.
285. Sminia T, van der Brugge Gamelkoorn GJ, Jeurissen SH. Structure and function of bronchus associated lymphoid tissue (BALT). Crit Rev Immunol 1989;9:119-150.
286. Van Cott JL, Brim TA, Lunney JK, Saif LJ. Contribution of antibody secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of coronavirus to immunity against enteric coronavirus challenge. J Immunol 1994;152:3980-3990.
287. Brandtzaeg P. Regionalized immune function of tonsils and adenoids. Immunol Today 1999;20:383-384.
288. Fukuizumi T, Inoue H, Tsujisawa T, Uchiyama C. Tonsillar application of formalin-killed cells of Streptococcus sobrinus reduces experimental dental caries in rabbits. Infect Immun 1999;67:426-428.
289. Inoue H, Fukuizumi T, Tsujisawa T, Uchiyama C. Simultaneous induction of specific immunoglobulin A-producing cells in major and minor salivary glands after tonsillar application of antigen in rabbits. Oral Microbiol Immunol 1999;14:21-26.
290. Nadal D, Albini B, Chen CY, Schläpfer E, Bernstein JM, Ogra PL. Distribution and engraftment patterns of human tonsillar mononuclear cells and immunoglobulin secreting cells in mice with severe combined immunodeficiency: role of the Epstein Barr virus. Int Arch Allergy Appl Immunol 1991;95:341-351.
291. Picker LJ, et al. Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol 1994;24:1269-1277.
292. Wagner N, et al. Critical role for β7 integrins in formation of the gut-associated lymphoid tissue. Nature 1996;382:366-370.
293. Abitorabi MA, Mackay CR, Jerome EH, Osorio O, Butcher EC, Erie DJ. Differential expression of homing molecules on recirculating lymphocytes from sheep gut, peripheral, and lung lymph. J Immunol 1996;156:3111-3117.
294. Quiding-Järbrink M, Granström G, Nordström I, Holmgren J, Czerkinsky C. Induction of compartmentalized B cell responses in human tonsils. Infect Immun 1995;63:853-857.
295. Csencsits KL, Pascual DW. Absence of L-selectin delays mucosal B cell responses in nonintestinal effector tissues. J Immunol 2002;169:S649-S659.
296. Lo JC, et al. Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues. J Clin Invest 2003;112:1495-1505.
297. Brandtzaeg P. Mucosal immunity in the female genital tract. J Reprod Immunol 1997;36:23-50.
298. Johansson EL, Wassén L, Holmgren J, Jertborn M, Rudin A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun 2001;69:7481-7486.
299. Kozlowski PA, et al. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol 2002;169:566-574.
300. Wu HY, Nguyen HH, Russell MW. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand J Immunol 1997;46:506-513.
301. Haneberg B, et al. Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans. Infect Immun 1998;66:1334-1341.
302. Oftung F, et al. Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine. Infect Immun 1999;67:921-927.
303. Rudin A, Johansson EL, Bergquist C, Holmgren J. Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans. Infect Immun 1998;66:3390-3396.
304. Crotty S, et al. Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors. J Virol 2001;75:7435-7452.
305. Bentley AM, et al. Expression of endothelial and leukocyte adhesion molecules interacellular adhesion molecule 1, E selectin, and vascular cell adhesion molecule 1 in the bronchial mucosa in steady state and allergen induced asthma. J Allergy Clin Immunol 1993;92:857-868.
306. Jahnsen FL, Haraldsen G, Aanesen JP, Haye R, Brandtzaeg P. Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Mol Biol 1995;12:624-632.
307. Wilson E, Butcher EC. CCL28 controls immunoglobulin (Ig) A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J Exp Med 2004;200:805-809
308. (Erratum in: J Exp Medical 2004;200:following 1089).
309. Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, Yoshie O. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J Immunol 2003;170:1136-1140.
310. Kang HS, et al. Signaling via LTβR on the lamina propria stromal cells of the gut is required for IgA production. Nat Immunol 2002;3:576-582.
311. Newberry RD, McDonough JS, McDonald KG, Lorenz RG. Postgestational lymphotoxin/lymphotoxin β receptor interactions are essential for the presence of intestinal B lymphocytes. J Immunol 2002;168:4988-4997.
312. Kremmidiotis G, Zola H. Changes in CD44 expression during B cell differentiation in the human tonsil. Cell Immunol 1995;161:147-157.
313. Cassese G, et al. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol 2003;171:1684-1690.
314. Halstead TE, Hall JG. The homing of lymph borne immunoblasts to the small gut of neonatal rats. Transplantation 1972;14:339-346.
315. Parrott DM, Ferguson A. Selective migration of lymphocytes within the mouse small intestine. Immunology 1974;26:571-588.
316. Bode U, Wonigeit K, Pabst R, Westermann J. The fate of activated T cells migrating through the body: rescue from apoptosis in the tissue of origin. Eur J Immunol 1997;27:2087-2093.
317. Matis LA, Glimcher LH, Paul WE, Schwartz RH. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci USA 1983;80:6019-6023.
318. Thrane PS, Sollid LM, Haanes HR, Brandtzaeg P. Clustering of IgA-producing immunocytes related to HLA-DR-positive ducts in normal and inflamed salivary glands. Scand J Immunol 1992;35:43-51.
319. Newman RA, Ormerod MG, Greaves MF. The presence of HLA-DR antigens on lactating human breast epithelium and milk fat globule membranes. Clin Exp Immunol 1980;41:478-486.
320. Merville P, et al. Bcl 2 + tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J Exp Med 1996;183:227-236.
321. Slifka MK, Ahmed R. Long lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol 1998;10:252-258.
322. Pierce NF, Gowans JL. Cellular kinetics of the intestinal immune response to cholera toxoid in rats. J Exp Med 1975;142:1550-1563.
323. Lange S, Nygren H, Svennerholm A-M, Holmgren J. Antitoxic cholera immunity in mice: influence of antigen deposition on antitoxin-containing cells and protective immunity in different parts of the intestine. Infect Immun 1980;28:17-23.
324. Husband AJ. Kinetics of extravasation and redistribution of IgA-specific antibody-containing cells in the intestine. J Immunol 1982;128:1355-1359.
325. Brandtzaeg P, Baklien K. Immunohistochemical studies of the formation and epithelial transport of immunoglobulins in normal and diseased human intestinal mucosa. Scand J Gastroenterol 1976;11 (Suppl 36):1-45.
326. Ogra PL, Karzon DT. The role of immunoglobulins in the mechanism of mucosal immunity to virus infection. Pediatr Clin North Am 1970;17:385-400.
327. Hopkins S, et al. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun 1995;63:3279-3286.
328. Kantele A, et al. Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21 a: evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun 1998;66:5630-5635.
329. Eriksson K, et al. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination. Infect Immun 1998;66:5889-5896.
330. Gütgemann I, Fahrer AM, Altman JD, Davis MM, Chien YH. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 1998;8:667-673.
331. Dunkley ML, Husband AJ. The role of non B cells in localizing an IgA plasma cell response in the intestine. Reg Immunol 1990-91;3:336-340.
332. Söltoft J, Söeberg B. Immunoglobulin-containing cells in the small intestine during acute enteritis. Gut 1972;13:535-538.
333. Agus SG, Falchuk ZM, Sessoms CS, Wyatt RG, Dolin R. Increased jejunal IgA synthesis in vitro during acute infectious non-bacterial gastroenteritis. Am J Dig Dis 1974;19:127-131.
334. Brandtzaeg P, Johansen F-E. Immunology of the gut. In: Desselberger U, Gray J, eds. Viral Gastroenteritis. In: Zuckerman AJ, Mushahwar LK, eds. Series: Perspectives in Medical Virology, Vol. 9 Elsevier, 2003:69-91.
335. Brandtzaeg P, Nilssen DE. Mucosal aspects of primary B-cell deficiency and gastrointestinal infections. Curr Opin Gastroenterol 1995;11:532-540.
336. Brandtzaeg P. Impact of immunodeficiency on immunological homeostasis in the gut. In: Lukáš M, Manns MP, Špièák J, Stange EF, eds. Falk Symposium 135 - Immunological Diseases of Liver and Gut. Dordrecht: Kluwer Academic Publishers, 2004:180-209.
337. Yamazaki K-I, Shimada S-I, Kato-Nagaoka N, Soga H, Itoh T, Nanno M. Accumulation of intestinal intraepithelial lymphocytes in association with lack of polymeric immunoglobulin receptor. Eur J Immunol 2005;35:1211-1219.
338. Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol 2004;4:953-964.